Form 4: Kiniksa Pharmaceuticals Executive Eben Tessari Reports Share Transactions
SEC Form 4 Filing
Eben Tessari, Chief Operating Officer of Kiniksa Pharmaceuticals International, plc, reports the acquisition and disposal of Class A Ordinary Shares on April 7, 2025.
Summary
- On April 7, 2025, Eben Tessari, the Chief Operating Officer of Kiniksa Pharmaceuticals International, plc, engaged in transactions involving the company's Class A Ordinary Shares.
- Tessari acquired 2,726 shares through the vesting of Restricted Share Units (RSUs).
- Additionally, Tessari disposed of 801 shares to cover tax obligations at a price of $20.28 per share.
- Following these transactions, Tessari directly owns 82,363 Class A Ordinary Shares and 2,726 Restricted Share Units.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing represents routine transactions related to executive compensation and tax obligations.
Positives
- The vesting of RSUs indicates a continued alignment of the executive's interests with those of the shareholders.
Future Outlook
The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, April 7, 2022, suggesting future transactions may occur as more units vest.
Industry Context
Form 4 filings are a routine part of regulatory compliance for publicly traded companies, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.
Stakeholder Impact
- The transactions provide transparency to shareholders regarding executive compensation and ownership.
Key Dates
| Date | Description |
|---|---|
| 04/07/2022 | Date of grant for the Restricted Share Units (RSUs), vesting over a four-year period. |
| 04/07/2025 | Date of the reported transactions: acquisition of shares through RSU vesting and disposal of shares for tax obligations. |
| 04/09/2025 | Date of signature for the Form 4 filing. |
Keywords
Kiniksa Pharmaceuticals, Eben Tessari, Class A Ordinary Shares, Restricted Share Units, RSU, Form 4, Beneficial Ownership, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.